ATRO Medical, a Radboudumc and DSM spin-off, is based in Uden and has an office in Nijmegen, where the company benefits from the expertise and facilities of Radboudumc. Jan Hunik, co-founder and CEO: "I am very pleased with this investment round and welcomes the trust in the Trammpolin® device at this stage of the development. The funds raised will enable the company to execute a second clinical study to demonstrate its potential to improve the quality of lives of patients".
Read the full article on ATRO Medical
image courtesy of ATRO Medical
Related news items
Survey of patients to address knee pain from removed meniscus
19 November 2021Patients with persistent knee pain after meniscus removal can participate at three locations in the Netherlands in the AIR2 study by ATRO Medical, a spin-off of the Radboudumc and DSM.
read more
Department of Medical Imaging takes fourth spot in world hospital rankings
29 October 2021US News rates the Department of Medical Imaging at Radboudumc with a fourth place in the international ranking of best global institutes for Radiology and Nuclear Medicine
read more
Ivy Medical enters next phase
28 October 2021In collaboration with Radboudumc, Ivy Medical has finished the first tests of the wearable intravenous dripping system.
read more
New start-up Patholyt will bring AI research into pathology diagnostics
21 September 2021Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.
read more
Radboudumc enhances Luchtbrug in collaboration with FindAir
17 August 2021Luchtbrug is a platform for online asthma care for children and young people, which (partly) replaces outpatient visits.
read more